CClinicalTrials.gg
Status unknownNCT04827082Updated Apr 1, 2021

Effects of Diacutaneous Fibrolysis on Flexibility and Active Neuromuscular Response

An interventional study of Diacutaneous fibrolysis in Hamstring Contractures, sponsored by Universitat Internacional de Catalunya. Status unknown at 1 site in Spain. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-01.

Sponsored by Universitat Internacional de Catalunya · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Mar 2021), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Diacutaneous fibrolysis is a physiotherapeutic instrumental technique, used to treat musculoskeletal conditions causing pain and/or movement restriction. It is applied by means of metallic hooks, ending in a spatula with beveled edges, that seems to allow a better pressure distribution on the skin and a deeper and more precise application, compared to the manual approach. Recent studies indicate positive responses regrading pain intensity decrease in sports people suffering anterior knee pain, improving range of motion in subacromial impingement syndrome, improving sensory conductivity in symptomatic patients with carpal tunnel syndrome, decreased pain in patients with chronic epicondialgia or improveing function athletes with anterior knee pain. However, the specific action mechanism, have not been investigated in depth yet. There are no studies evaluating its effects on posterior muscular chain of lower extremity in athletes, where FD effects on neuromuscular response could be more evident due to the overload involved on this area. The aim of this study is to evaluate the immediate, and after 30 minutes, effects of a single diacutaneous fibrolysis session on flexibility, strength and neuromuscular activity on hamstring in athletes. A randomized controlled trial with blind evaluator. Randomization will be done between lower extremities of each subject (Random.org). Regardless of its own dominance, diacutaneous fibrolysis will be applied to de following muscles and intermuscular septums: gluteus maixmus, biceps femoris and semitendinosus to de lower experimental limb. The other extremity will not be treat (control limb).

Sample recruitment. Athletes from UIC university community, who compete officially or institutionally, whether they are federated or recorded in a sport official register where the predominant activity focuses on the lower train (athletics, cycling, football, rugby...). Procedure. The anthropometric data will be collected at the beginning of the study. Each outcome assessment will be performed by a blinded evaluator at the baseline, immediately after the technique application and 30 minutes after.

02

Conditions studied

  • Hamstring Contractures

Browse trials for

Keywords

  • Diacutaneous fibrolysis
  • Physiotherapy
  • Neuromuscular response
03

In context

Contracture

151 studies on the registry are indexed under Contracture; 21 are open to participants now.

This study's planned enrollment of 66 is above the median of 40 across 110 interventional studies indexed under Contracture.

Browse Contracture studies →

Lead sponsor

Universitat Internacional de Catalunya is the lead sponsor of 144 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Athletes
  • \<160º in the Passive Knee Extension test
  • Participants must sign and have informed consent.

Exclusion criteria

Exclusion Criteria:

  • Poor skin
  • Trophic condition
  • Taking anticoagulants
  • Inflammatory process
  • Recent musculoskeletal lower limb injury (\< 6 month)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    Diacutaneous fibrolysis group

    Diacutaneous fibrolysis is a physiotherapeutic instrumental technique, used to treat musculoskeletal conditions causing pain and/or movement restriction. It is applied by means of metallic hooks, ending in a spatula with beveled edges. Regardless of its own dominance, diacutaneous fibrolysis will be applied to de following muscles and intermuscular septums: gluteus maximus, biceps femoris and semitendinosus to de lower experimental limb. A single session of 10 minutes will be applied.

    Other: Diacutaneous fibrolysis

  • No intervention
    Control group

    Participants will be used as their own controls, with one lower extremity randomly receiving intervention. The control extremity will not receive any intervention

Interventions

  • OtherDiacutaneous fibrolysis

    Diacutaneous fibrolysis is a physiotherapeutic instrumental technique, used to treat musculoskeletal conditions causing pain and/or movement restriction. It is applied by means of metallic hooks, ending in a spatula with beveled edges. Regardless of its own dominance, diacutaneous fibrolysis will be applied to de following muscles and intermuscular septums: gluteus maximus, biceps femoris and semitendinosus to de lower experimental limb. A single session of 10 minutes will be applied.

06

What researchers measure

Primary outcomes

  1. Hamstring neuromuscular activity

    Hamstring neuromuscular activity (% of muscular fiber recruitment) will be assessed by surface electromyogram (mDurance). The electrodes will be placed on hamstring muscle while performing a functional movement.

    Time frame: Change between baseline (immediately before intervention) and post intervention (immediately after intervention); Change between baseline (immediately before intervention) and 30 minutes after intervention]

  2. Gluteus maximus neuromuscular activity

    Gluteus maximus neuromuscular activity (% of muscular fiber recruitment) will be assessed by surface electromyogram (mDurance). The electrodes will be placed on gluteus maximus muscle while performing a functional movement.

    Time frame: Change between baseline (immediately before intervention) and post intervention (immediately after intervention); Change between baseline (immediately before intervention) and 30 minutes after intervention]

  3. Hamstring isometric strength

    Isometric muscle strength (Kg) will be evaluated by means of a digital dynamometer (Microfeet 2). This measures will be taken across a knee flexion.

    Time frame: Change between baseline (immediately before intervention) and post intervention (immediately after intervention); Change between baseline (immediately before intervention) and 30 minutes after intervention]

  4. Guteus maximus isometric strength

    Isometric muscle strength (Kg) will be evaluated by means of a digital dynamometer (Microfeet 2). This measures will be measured by means of hip extension.

    Time frame: Change between baseline (immediately before intervention) and post intervention (immediately after intervention); Change between baseline (immediately before intervention) and 30 minutes after intervention]

  5. Height on counter movement jump

    Height (centimeters) on counter movement jump will be assessed using a mobile application called "My jump". Its data has been used as an indirect indicator of explosive muscular strength of lower limb

    Time frame: Change between baseline (immediately before intervention) and post intervention (immediately after intervention); Change between baseline (immediately before intervention) and 30 minutes after intervention]

  6. Time flight on counter movement jump

    Time flight (milliseconds) on counter movement jump will be assessed using a mobile application called "My jump".

    Time frame: Change between baseline (immediately before intervention) and post intervention (immediately after intervention); Change between baseline (immediately before intervention) and 30 minutes after intervention]

  7. Force on counter movement jump

    Force (newtons) on counter movement jump will be assessed using a mobile application called "My jump".

    Time frame: Change between baseline (immediately before intervention) and post intervention (immediately after intervention); Change between baseline (immediately before intervention) and 30 minutes after intervention]

  8. Back chain flexibility Changes

    Back chain flexibility is going to be assessed by means of modified Back Saver Sit and reach test (centimeters).

    Time frame: Change between baseline (immediately before intervention) and post intervention (immediately after intervention); Change between baseline (immediately before intervention) and 30 minutes after intervention]

  9. Hamstring flexibility changes

    Hamstring muscles flexibility will be assessed using the passive knee extension test (degrees) by means of goniometer.

    Time frame: Change between baseline (immediately before intervention) and post intervention (immediately after intervention); Change between baseline (immediately before intervention) and 30 minutes after intervention]

07

Study locations

1 of 1 sites recruiting
  • Universitat Internacional de Catalunya
    Sant Cugat Del Vallès, Barcelona 08195, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 1, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04827082
Lead sponsor
Universitat Internacional de Catalunya
Responsible party
Aida Cadellans Arróniz (Principal Investigator, Universitat Internacional de Catalunya) — Principal investigator
First posted
Apr 1, 2021
Start date
Apr 1, 2021 (estimated)
Primary completion
May 1, 2021 (estimated)
Completion
Jul 1, 2021 (estimated)
Last update
Apr 1, 2021

Study contacts

Aida C Arróniz, MsC
Contact
acadellans@uic.es
635246977

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion